Study Information
| Title: | A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation  |
| Status: | Recruiting participants |
| Conditions: | Melanoma |
| Interventions: | Drug: nilotinib (AMN107) |
| Institutions: | Dana-Farber Cancer Institute |
| Health Topics: | Melanoma |
Contact Information
Dana Farber Cancer Center
Boston, MA 02115
Meredith Davis
617-582-8687
Meredith_Davis@dfci.harvard.edu